DBD Stock Summary and Trading Ideas (Diebold Nixdorf | NYSE:DBD)

Diebold Nixdorf Inc is engaged in providing software and hardware services for financial and retail industries. The customer segments of the company are banking which offers integrated solutions for financial institutions and retail which offers solutions, software, and services which improve the checkout process for retailers.

Diebold Nixdorf trades on the NYSE stock market under the symbol DBD.

As of January 31, 2025, DBD stock price climbed to $43.52 with 737 million shares trading.

DBD has a beta of 0.91, meaning it tends to be less sensitive to market movements. DBD has a correlation of 0.08 to the broad based SPY ETF.

DBD has a market cap of $1.63 billion. This is considered a Small Cap stock.

Last quarter Diebold Nixdorf reported $927 million in Revenue and $.53 earnings per share. This fell short of revenue expectation by $-2 million and missed earnings estimates by -$.61.

The top ETF exchange traded funds that DBD belongs to (by Net Assets): VTI, IWM, VXF, VGT, IWN.

DBD has outperformed the market in the last year with a return of +43.8%, while the SPY ETF gained +25.2%. However, in the most recent history, DBD shares have underperformed the stock market with its stock returning -8.5% in the last 3 month period and +1.2% for the last 2 week period, while SPY has returned +5.1% and +2.7%, respectively.

DBD support price is $42.53 and resistance is $44.39 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DBD shares will trade within this expected range on the day.